{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T06:26:21Z","timestamp":1794119181415,"version":"4.8.0"},"reference-count":18,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T00:00:00Z","timestamp":1747094400000},"content-version":"unspecified","delay-in-days":12,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"RILITE Foundation"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Lupus Sci Med"],"accepted":{"date-parts":[[2025,4,9]]},"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>We previously described a classification system of persons with SLE based on whole blood RNA profiles and a random forest (RF) algorithm to predict individual patient endotypes. Here, we apply this algorithm prospectively in an independent set of patients to validate its use as a staging biomarker.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Whole blood from 101 patients participating in three clinical trials (<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT03626311\">NCT03626311<\/jats:ext-link>,  <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT03180021\">NCT03180021<\/jats:ext-link> and <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT05845593\">NCT05845593<\/jats:ext-link>) meeting American College of Rheumatology (ACR) or Systemic Lupus Collaborating Clinics (SLICC) criteria for SLE classification was obtained at baseline, and RNA isolated and sequenced. Gene expression values were used as input to gene set variation analysis (GSVA), and the RF algorithm was applied using GSVA enrichment scores of 32 informative gene sets as input. Composite scores summarising gene expression perturbations were assigned to each patient using a ridge logistic regression algorithm.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Patients with SLE were subset into eight endotypes identified by the algorithm. Patterns of gene enrichment in the identified endotypes mirrored those found in the previously reported endotypes. Differences in clinical characteristics, including serum complement levels, autoantibody positivity and the presence of nephritis, were observed between patients in various endotypes. Patients with active, concurrent nephritis were disproportionately assigned to the more molecularly perturbed endotypes. Composite scores were significantly, but modestly, inversely correlated with complement but not SLE Disease Activity Index (SLEDAI) or anti-double-stranded DNA antibody (anti-dsDNA) titre.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The identification of eight molecular endotypes of lupus based on whole blood gene expression was validated in an independent data set of diverse patients. Endotyping patients with SLE based on transcriptional profiles can provide important status (presence of nephritis) information and provide novel molecular insights in support of personalised management.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/lupus-2025-001526","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T02:55:17Z","timestamp":1747191317000},"page":"e001526","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":13,"title":["Validation of eight endotypes of lupus based on whole-blood RNA profiles"],"prefix":"10.1136","volume":"12","clinical-trial-number":[{"clinical-trial-number":"nct03626311","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct03180021","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct05845593","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct03626311","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct03180021","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct05845593","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct03626311","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct03180021","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct03142711","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct03180021","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct03626311","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct03626311","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct03626311","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct05845593","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct03180021","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct03180021","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct05845593","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct05845593","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7972-2879","authenticated-orcid":false,"given":"Erika","family":"Hubbard","sequence":"first","affiliation":[{"name":"Bioinformatics and Biostatistics, The George Washington University, Washington, District of Columbia, USA"},{"name":"AMPEL BioSolutions LLC, Charlottesville, Virginia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prathyusha","family":"Bachali","sequence":"additional","affiliation":[{"name":"AMPEL BioSolutions LLC, Charlottesville, Virginia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amrie C","family":"Grammer","sequence":"additional","affiliation":[{"name":"AMPEL BioSolutions LLC, Charlottesville, Virginia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter E","family":"Lipsky","sequence":"additional","affiliation":[{"name":"AMPEL BioSolutions LLC, Charlottesville, Virginia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,5,13]]},"reference":[{"key":"2025091511592115000_12.1.e001526.1","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/s41584-023-00948-y","article-title":"Precision medicine in systemic lupus erythematosus","volume":"19","author":"Fasano","year":"2023","journal-title":"Nat Rev Rheumatol"},{"key":"2025091511592115000_12.1.e001526.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2020.09.009"},{"key":"2025091511592115000_12.1.e001526.3","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-218272"},{"key":"2025091511592115000_12.1.e001526.4","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-020-0743-0"},{"key":"2025091511592115000_12.1.e001526.5","doi-asserted-by":"crossref","DOI":"10.1186\/s13073-023-01237-9","article-title":"Analysis of transcriptomic features reveals molecular endotypes of SLE with clinical implications","volume":"15","author":"Hubbard","year":"2023","journal-title":"Genome Med"},{"key":"2025091511592115000_12.1.e001526.6","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinformatics"},{"key":"2025091511592115000_12.1.e001526.7","unstructured":"Lundberg SM , Lee S . A unified approach to interpreting model predictions. Advances in Neural Information Processing Systems; 2017"},{"key":"2025091511592115000_12.1.e001526.8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1145\/3561048","article-title":"Explainable AI (XAI): core ideas, techniques, and solutions","volume":"55","author":"Dwivedi","year":"2023","journal-title":"ACM Comput Surv"},{"key":"2025091511592115000_12.1.e001526.9","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.140380","article-title":"Patient ancestry significantly contributes to molecular heterogeneity of systemic lupus erythematosus","volume":"5","author":"Catalina","year":"2020","journal-title":"JCI Insight"},{"key":"2025091511592115000_12.1.e001526.10","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2015.151"},{"key":"2025091511592115000_12.1.e001526.11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM196803072781004"},{"key":"2025091511592115000_12.1.e001526.12","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2020.100291","article-title":"Adults with systemic lupus exhibit distinct molecular phenotypes in a cross-sectional study","volume":"20","author":"Guthridge","year":"2020","journal-title":"EClinicalMedicine"},{"key":"2025091511592115000_12.1.e001526.13","doi-asserted-by":"crossref","unstructured":"Bachali P , Grammer A , Lipsky P . Identification of subsets of SLE patients responsive to baricitinib by transcriptomic analysis at baseline [abstract]. Arthritis Rheumatol 2023;75. doi:10.1136\/annrheumdis-2023-eular.4878","DOI":"10.1136\/annrheumdis-2023-eular.4878"},{"key":"2025091511592115000_12.1.e001526.14","unstructured":"Bachali P , Korish S , Hu Y , et al . Transcriptomic analysis of the impact of iberdomide on patients with SLEl [abstract]. Arthritis Rheumatol 2023;75. Available: https:\/\/acrabstracts.org\/abstract\/transcriptomic-analysis-of-the-impact-of-iberdomide-on-patients-with-sle\/"},{"key":"2025091511592115000_12.1.e001526.15","unstructured":"R Core Team . R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing, 2024. Available: https:\/\/www.R-project.org\/"},{"key":"2025091511592115000_12.1.e001526.16","doi-asserted-by":"crossref","DOI":"10.1002\/imt2.43","article-title":"Complex heatmap visualization","volume":"1","author":"Gu","year":"2022","journal-title":"Imeta"},{"key":"2025091511592115000_12.1.e001526.17","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btu393"},{"key":"2025091511592115000_12.1.e001526.18","doi-asserted-by":"crossref","unstructured":"Wickham H . Ggplot2: elegant graphics for data analysis. New York: Springer-Verlag New York, 2016.","DOI":"10.1007\/978-3-319-24277-4_9"}],"container-title":["Lupus Science &amp; Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/lupus-2025-001526","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T18:59:31Z","timestamp":1757962771000},"score":1,"resource":{"primary":{"URL":"https:\/\/lupus.bmj.com\/lookup\/doi\/10.1136\/lupus-2025-001526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,5,13]]},"published-print":{"date-parts":[[2025,5]]}},"alternative-id":["10.1136\/lupus-2025-001526"],"URL":"https:\/\/doi.org\/10.1136\/lupus-2025-001526","relation":{},"ISSN":["2053-8790"],"issn-type":[{"value":"2053-8790","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5]]}}}